300267 爾康製藥
按盤價 
2.120 +0.040 (+1.923%)
2.120 +0.040 (+1.923%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.060 | -3.951 | 0.928 | -14.841 | 3.310 |
| 總資產報酬率 ROA (%) | 0.053 | -3.446 | 0.814 | -13.090 | 3.168 |
| 投入資產回報率 ROIC (%) | 0.055 | -3.606 | 0.856 | -13.752 | 3.038 | 邊際利潤分析 |
| 銷售毛利率 (%) | 29.873 | 20.424 | 22.220 | 23.341 | 22.781 |
| 營業利潤率 (%) | 0.304 | -11.593 | 0.737 | -36.619 | 9.134 |
| 息稅前利潤/營業總收入 (%) | -0.163 | -11.151 | 1.634 | -37.606 | 8.990 |
| 淨利潤/營業總收入 (%) | -0.104 | -12.442 | 1.982 | -35.710 | 7.613 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -1,676.644 | 56.875 | -66.062 | -4.149 | 51.442 |
| 價值變動淨收益/利潤總額(%) | 118.913 | 4.561 | 108.424 | -2.050 | 61.592 |
| 營業外收支淨額/利潤總額(%) | -12.143 | -3.917 | 20.596 | 3.219 | -7.969 | 償債能力分析 |
| 流動比率 (X) | 2.782 | 2.869 | 2.883 | 3.901 | 3.554 |
| 速動比率 (X) | 1.651 | 1.723 | 1.750 | 2.468 | 2.553 |
| 資產負債率 (%) | 12.559 | 12.211 | 13.740 | 10.278 | 12.300 |
| 帶息債務/全部投入資本 (%) | 7.083 | 7.075 | 7.715 | 5.016 | -- |
| 股東權益/帶息債務 (%) | 1,294.205 | 1,295.790 | 1,177.652 | 1,870.734 | 1,255.416 |
| 股東權益/負債合計 (%) | 700.469 | 722.818 | 627.794 | 868.961 | 709.672 |
| 利息保障倍數 (X) | 0.375 | -2,082.766 | 2.314 | -162.266 | 16.962 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 35.563 | 24.515 | 30.811 | 43.507 | 0.000 |
| 存貨周轉天數 (天) | 324.093 | 191.927 | 190.048 | 154.502 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 01/07/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
